Eyebright Medical (China) Performance
| 688050 Stock | 90.61 1.90 2.05% |
On a scale of 0 to 100, Eyebright Medical holds a performance score of 4. The firm shows a Beta (market volatility) of 0.65, which means possible diversification benefits within a given portfolio. As returns on the market increase, Eyebright Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eyebright Medical is expected to be smaller as well. Please check Eyebright Medical's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Eyebright Medical's price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Eyebright Medical Technology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Eyebright Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0055 | Payout Ratio 0.187 | Last Split Factor 1.8:1 | Forward Dividend Rate 0.49 | Ex Dividend Date 2024-06-05 |
1 | 3 Growth Companies With Insider Ownership Up To 21 percent - Simply Wall St | 12/02/2024 |
| Begin Period Cash Flow | 350 M |
Eyebright |
Eyebright Medical Relative Risk vs. Return Landscape
If you would invest 8,254 in Eyebright Medical Technology on September 26, 2024 and sell it today you would earn a total of 807.00 from holding Eyebright Medical Technology or generate 9.78% return on investment over 90 days. Eyebright Medical Technology is generating 0.2389% of daily returns and assumes 4.1735% volatility on return distribution over the 90 days horizon. Simply put, 37% of stocks are less volatile than Eyebright, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Eyebright Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eyebright Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Eyebright Medical Technology, and traders can use it to determine the average amount a Eyebright Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0572
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688050 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.17 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Eyebright Medical is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eyebright Medical by adding it to a well-diversified portfolio.
Eyebright Medical Fundamentals Growth
Eyebright Stock prices reflect investors' perceptions of the future prospects and financial health of Eyebright Medical, and Eyebright Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eyebright Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0872 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 16.91 B | ||||
| Shares Outstanding | 189.54 M | ||||
| Price To Book | 7.20 X | ||||
| Price To Sales | 12.91 X | ||||
| Revenue | 951.18 M | ||||
| Gross Profit | 491.15 M | ||||
| EBITDA | 506.62 M | ||||
| Net Income | 304.43 M | ||||
| Total Debt | 117.94 M | ||||
| Book Value Per Share | 12.29 X | ||||
| Cash Flow From Operations | 212.62 M | ||||
| Earnings Per Share | 1.95 X | ||||
| Total Asset | 3.06 B | ||||
| Retained Earnings | 647.18 M | ||||
About Eyebright Medical Performance
By analyzing Eyebright Medical's fundamental ratios, stakeholders can gain valuable insights into Eyebright Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Eyebright Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eyebright Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Eyebright Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Eyebright Medical performance evaluation
Checking the ongoing alerts about Eyebright Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eyebright Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eyebright Medical had very high historical volatility over the last 90 days | |
| Eyebright Medical is unlikely to experience financial distress in the next 2 years | |
| About 38.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: 3 Growth Companies With Insider Ownership Up To 21 percent - Simply Wall St |
- Analyzing Eyebright Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eyebright Medical's stock is overvalued or undervalued compared to its peers.
- Examining Eyebright Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eyebright Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eyebright Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eyebright Medical's stock. These opinions can provide insight into Eyebright Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Eyebright Stock analysis
When running Eyebright Medical's price analysis, check to measure Eyebright Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyebright Medical is operating at the current time. Most of Eyebright Medical's value examination focuses on studying past and present price action to predict the probability of Eyebright Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyebright Medical's price. Additionally, you may evaluate how the addition of Eyebright Medical to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |